Year |
Citation |
Score |
2017 |
Kandalkar SR, Ramaiah PA, Joshi M, Wavhal A, Waman Y, Raje AA, Tambe A, Ansari S, De S, Palle VP, Mookhtiar KA, Deshpande AM, Barawkar DA. Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors. Bioorganic & Medicinal Chemistry. PMID 28951094 DOI: 10.1016/J.Bmc.2017.09.015 |
0.553 |
|
2017 |
Deshpande AM, Bhuniya D, De S, Dave B, Vyavahare VP, Kurhade SH, Kandalkar SR, Naik KP, Kobal BS, Kaduskar RD, Basu S, Jain V, Patil P, Chaturvedi Joshi S, Bhat G, et al. Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia. European Journal of Medicinal Chemistry. 133: 268-286. PMID 28390958 DOI: 10.1016/J.Ejmech.2017.03.042 |
0.302 |
|
2013 |
Kandalkar SR, Kaduskar RD, Ramaiah PA, Barawkar DA, Bhuniya D, Deshpande AM. Highly efficient one-pot amination of carboxylate-substituted nitrogen-containing heteroaryl chlorides via Staudinger reaction Tetrahedron Letters. 54: 414-418. DOI: 10.1016/J.Tetlet.2012.11.027 |
0.537 |
|
2012 |
Barawkar DA, Bandyopadhyay A, Deshpande A, Koul S, Kandalkar S, Patil P, Khose G, Vyas S, Mone M, Bhosale S, Singh U, De S, Meru A, Gundu J, Chugh A, et al. Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase. Bioorganic & Medicinal Chemistry Letters. 22: 4341-7. PMID 22658862 DOI: 10.1016/J.Bmcl.2012.05.020 |
0.602 |
|
2011 |
Barawkar DA, Meru A, Bandyopadhyay A, Banerjee A, Deshpande AM, Athare C, Koduru C, Khose G, Gundu J, Mahajan K, Patil P, Kandalkar SR, Niranjan S, Bhosale S, De S, et al. Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats. Acs Medicinal Chemistry Letters. 2: 919-23. PMID 24900281 DOI: 10.1021/Ml2001938 |
0.591 |
|
2011 |
Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, et al. Erratum to “RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes” [European Journal of Pharmacology 652 (1–3) (2011) 157–163] European Journal of Pharmacology. 655: 121. DOI: 10.1016/J.Ejphar.2011.02.004 |
0.323 |
|
Low-probability matches (unlikely to be authored by this person) |
2011 |
Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, et al. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes. European Journal of Pharmacology. 652: 157-63. PMID 20540938 DOI: 10.1016/j.ejphar.2010.06.001 |
0.217 |
|
2023 |
Thete SG, Deshmukh A, Yadav R, Umbare D, Shinde KN, Kandalkar S. A Comparative Evaluation of Collagen in Ameloblastoma and Oral Squamous Cell Carcinoma using Picrosirius Red Staining with Polarizing Microscopy and CD44v6 Immunoreactivity. Journal of Pharmacy & Bioallied Sciences. 15: S952-S955. PMID 37694046 DOI: 10.4103/jpbs.jpbs_269_23 |
0.059 |
|
Hide low-probability matches. |